Efficacy and Safety of Novel 5-HT4 Agonist DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Early Phase II Study.
Efficacy and Safety of Novel 5-HT4 Agonist DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Early Phase II Study.
复制标题
新型 5-HT4 激动剂 DSP-6952 对肠易激综合征伴便秘患者的疗效和安全性：一项随机、双盲、安慰剂对照的早期 II 期研究。
DOI：
--
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Hiroto Miwa.
中科院分区：
文献类型：
--
作者：
Shin Fukudo;Masatoshi Nakamura;Hiroto Miwa.
